A Double-Blind, Randomized, Multicenter Study With 500 mg QD of TRO19622 Versus Placebo in Patients With Painful Peripheral Diabetic Neuropathy.
Phase of Trial: Phase II
Latest Information Update: 24 Nov 2016
At a glance
- Drugs Olesoxime (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Sponsors Roche; Trophos
- 26 Jan 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 26 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jun 2006 New trial record.